Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:e22
Published online before print February 26, 2007, doi: 10.1161/01.HYP.0000259961.27920.35
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
49/4/e22    most recent
01.HYP.0000259961.27920.35v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Granger, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Granger, J. P.
Related Collections
Right arrow Animal models of human disease
Right arrow Growth factors/cytokines
Right arrow Hypertension - basic studies
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2007;49:e22.)
© 2007 American Heart Association, Inc.


Letters to the Editor

Response to Modeling Preeclampsia: The True Model for the Uniquely Human Disease Preeclampsia Is the Human Female Not the Pregnant Rat

Joey P. Granger

University of Mississippi Medical Center, Jackson, Miss


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

We recently reported in Hypertension1 that the elevation in arterial pressure in pregnant rats with placental ischemia was associated with significant increases in serum interleukin (IL)-6. Moreover, we found that chronic elevation in serum levels of IL-6, comparable to levels observed in our placental ischemic pregnant rat model, resulted in significant increases in arterial pressure and decreases in renal hemodynamics in pregnant rats. These results led us to conclude that IL-6 may play a role in mediating the hypertension and reduction in renal hemodynamics observed with placental ischemia in pregnant rats.1

Nama et al2 expressed concerns and indicated that "there is no adequate laboratory model of preeclampsia" and that no animal model "develops a condition during pregnancy that remotely resembles preeclampsia." They also suggested that, "any significant progress in the field of preeclampsia research can only realistically come from studies of the human model."

Although we agree that rats may not spontaneously develop preeclampsia, we believe that our rat model provides an excellent opportunity to study the relationship between placental ischemia and hypertension. Although placental ischemia has been proposed to lead to widespread endothelial dysfunction, vasoconstriction, and hypertension in the maternal circulation during preeclampsia, the mechanisms that link placental ischemia and cardiovascular and renal dysfunction have yet to be fully elucidated. We reported previously that reducing uteroplacental perfusion pressure results in significant and consistent elevations in arterial pressure associated with proteinuria; reductions in renal plasma flow and glomerular filtration rate, an endothelial dysfunction; and intrauterine growth restriction.3–10

Collectively, these data . . . [Full Text of this Article]